UBS AM’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.01M Buy
268,903
+74,910
+39% +$1.4M ﹤0.01% 1702
2025
Q1
$3.72M Buy
193,993
+16,254
+9% +$311K ﹤0.01% 1712
2024
Q4
$6.4M Buy
177,739
+30,133
+20% +$1.09M ﹤0.01% 1478
2024
Q3
$6.26M Sell
147,606
-5,546
-4% -$235K ﹤0.01% 1455
2024
Q2
$6.17M Buy
153,152
+49,373
+48% +$1.99M ﹤0.01% 1382
2024
Q1
$3.67M Buy
103,779
+11,309
+12% +$400K ﹤0.01% 1393
2023
Q4
$2.74M Sell
92,470
-2,677
-3% -$79.2K ﹤0.01% 1532
2023
Q3
$1.98M Buy
95,147
+3,194
+3% +$66.3K ﹤0.01% 1633
2023
Q2
$3.73M Hold
91,953
﹤0.01% 1364
2023
Q1
$3.73M Buy
91,953
+3,585
+4% +$146K ﹤0.01% 1364
2022
Q4
$3.97M Buy
88,368
+5,910
+7% +$266K ﹤0.01% 1245
2022
Q3
$3.95M Sell
82,458
-11,675
-12% -$559K ﹤0.01% 1285
2022
Q2
$5.57M Sell
94,133
-2,183
-2% -$129K ﹤0.01% 1175
2022
Q1
$11.2M Buy
96,316
+6,418
+7% +$746K ﹤0.01% 1026
2021
Q4
$13.5M Sell
89,898
-4,889
-5% -$736K 0.01% 1016
2021
Q3
$11.3M Buy
94,787
+1,595
+2% +$190K ﹤0.01% 1045
2021
Q2
$9.08M Buy
93,192
+7,510
+9% +$731K ﹤0.01% 1153
2021
Q1
$7.56M Sell
85,682
-123,245
-59% -$10.9M ﹤0.01% 1178
2020
Q4
$20M Buy
208,927
+5,704
+3% +$546K 0.01% 852
2020
Q3
$23.1M Buy
203,223
+3,132
+2% +$355K 0.01% 730
2020
Q2
$19.8M Buy
200,091
+14,196
+8% +$1.4M 0.01% 742
2020
Q1
$12M Sell
185,895
-45,079
-20% -$2.9M 0.01% 816
2019
Q4
$13.8M Buy
230,974
+175,380
+315% +$10.5M 0.01% 859
2019
Q3
$3.28M Buy
55,594
+8,666
+18% +$511K ﹤0.01% 1387
2019
Q2
$3.03M Buy
46,928
+5,768
+14% +$372K ﹤0.01% 1401
2019
Q1
$2.61M Buy
41,160
+3,137
+8% +$199K ﹤0.01% 1394
2018
Q4
$1.44M Buy
+38,023
New +$1.44M ﹤0.01% 1574
2014
Q3
Sell
-19,070
Closed -$3.1M 2584
2014
Q2
$3.1M Sell
19,070
-2,150
-10% -$350K ﹤0.01% 1172
2014
Q1
$4.69M Sell
21,220
-3,580
-14% -$791K 0.01% 1051
2013
Q4
$6.39M Buy
+24,800
New +$6.39M 0.01% 947